Tesla unveils autonomous robotaxi

Tesla unveils autonomous robotaxi

U.S. electric vehicle maker Tesla Inc. unveils the autonomous robotaxi named "Cybercab" that has no steering wheel, accelerator pedal, or brake pedal, enabling fully driverless operation in Tokyo on Sept. 11, 2026.

  • Product Code
  • ILEA005093048
  • Registered date
  • 2026/9/11 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2026 Kyodo News
  • Media size
  • 3968 × 2645 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 1.17(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

    [Breaking News]Tesla unveils driverless Cybercab in Japan

    TOKYO, Japan, Sept. 11 Kyodo - U.S. electric vehicle maker Tesla Inc. unveils the Cybercab, its purpose-built autonomous robotaxi with no steering wheel, accelerator pedal, or brake pedal, in Tokyo on Sept. 11, 2026. (Kyodo)
      CORRECTED: Tesla unveils driverless Cybercab in Japan

      CORRECTED: Tesla unveils driverless Cybercab in Japan

      U.S. electric vehicle maker Tesla Inc. unveils the Cybercab, its purpose-built autonomous robotaxi with no steering wheel, accelerator pedal, or brake pedal, in Tokyo on Sept. 11, 2026.
        CORRECTED: Tesla unveils driverless Cybercab in Japan

        CORRECTED: Tesla unveils driverless Cybercab in Japan

        U.S. electric vehicle maker Tesla Inc. unveils the Cybercab, its purpose-built autonomous robotaxi with no steering wheel, accelerator pedal, or brake pedal, in Tokyo on Sept. 11, 2026.
          Japanese winners of U.S. Lasker Award

          Japanese winners of U.S. Lasker Award

          (From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. pose for a photo during a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.
            Japanese winners of U.S. Lasker Award

            Japanese winners of U.S. Lasker Award

            (From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. attend a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.
              Japanese winners of U.S. Lasker Award

              Japanese winners of U.S. Lasker Award

              (From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. attend a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.
                Japanese winners of U.S. Lasker Award

                Japanese winners of U.S. Lasker Award

                (From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. attend a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.
                  Japanese winners of U.S. Lasker Award

                  Japanese winners of U.S. Lasker Award

                  (From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. pose for a photo during a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.
                    Japanese winner of U.S. Lasker Award

                    Japanese winner of U.S. Lasker Award

                    Japanese researcher Kunihiro Hattori of Chugai Pharmaceutical Co. attends a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research. Hattori shared the award with fellow Chugai researchers Takehisa Kitazawa and Tomoyuki Igawa for their contributions to the development of a treatment for hemophilia.
                      Japanese winner of U.S. Lasker Award

                      Japanese winner of U.S. Lasker Award

                      Japanese researcher Takehisa Kitazawa of Chugai Pharmaceutical Co. attends a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research. Kitazawa shared the award with fellow Chugai researchers Kunihiro Hattori and Tomoyuki Igawa for their contributions to the development of a treatment for hemophilia.